Lilly To Provide Detailed Update Of Pipeline And R&D Strategy At Upcoming Investment Community Meeting

Eli Lilly and Company announced it will host a meeting for the investment community, including institutional investors, sell-side analysts, ratings agency representatives, and financial and business media.

World pharma today/Industry reports/- The meeting will take place Tuesday, May 24, 2016, from 10:00 a.m. (EDT) until approximately 3:00 p.m., inNew York City.

The investment community meeting will focus on Lilly’s research and development opportunities in diabetes, immunology, oncology and pain. It follows a similar meeting in December 2015 to review the company’s broad Alzheimer’s disease pipeline. The presentations will include discussion of new indications and line extensions for a number of established products as well as late-stage and select earlier-stage new molecular entities. There will be Q&A opportunities throughout the meeting.

A live webcast of the Lilly investment community meeting, along with presentation slides, will be available through a link on the investor section of Lilly’s website at https://investor.lilly.com/events.cfm. An audio replay will also be available for approximately one month.

Because of limited space, advance registration is required. Media interested in attending in person should contactMolly McCully at (317) 478-5423. Investors interested in attending should contact Edward Villacorta at (317) 433-1805.